Molina Healthcare Inc

Molina Healthcare Inc(MOH)股票分析

$214.900

-4.706 (-2.19%)收盘时

Loading chart…
最高
221.680
开盘
221.000
成交量加权均价
216.08
成交量
1.18M
市值
17.74B
最低
211.660
成交额
254.14M
企业价值/息税折旧摊销前利润(TTM)
11.83

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.

AI 分析 of Molina Healthcare Inc (MOH)

持有

Molina Healthcare Inc is currently trading at $207.36, which is below several analyst price targets, including $220 from Wells Fargo and $218 from RBC Capital. The company has shown a solid year-to-date change of +16.19%, indicating positive momentum. However, the recent insider selling increased by 4513.69%, which raises concerns about future performance. Given these mixed signals, a hold is recommended as the stock approaches key resistance levels around $213.35, while the risks associated with insider selling and fluctuating earnings estimates suggest caution.

分析师评级(13)

-15.84% 下跌空间
持有
4 买入
8 持有
1 卖出
当前: 214.90
最低
155.00
平均
180.85
最高
250.00

Wells Fargo

2026-07-28

目标价

$220

Equal Weight

RBC Capital

2026-07-24

目标价

$218

Sector Perform

Barclays

2026-07-24

目标价

$180

减持

BofA

2026-07-23

目标价

$260

买入

Truist

2026-07-14

目标价

$250

持有

估值指标

Molina Healthcare Inc(MOH)当前预期市盈率为 18.90,5 年平均预期市盈率为 16.36。

预期市盈率

合理
5 年均值 P/E
16.36
当前P/E
18.90
高估
23.11
低估
9.62

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
8.20
当前EV/EBITDA
11.83
高估
11.91
低估
4.49

预期市销率

低估
5 年均值 P/S
0.43
当前P/S
0.23
高估
0.59
低估
0.28

Alphio AI 对 MOH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%MOH

$381.71

情景价格

基

基准

基准 · 50%MOH

$347.68

情景价格

悲

悲观

悲观 · 25%MOH

$346.18

情景价格

持有 MOH 的大户

V

Vulcan Value Partners, LLC

+ 持有MOH

+9.59%

3个月收益率

S

South Dakota Investment Council

+ 持有MOH

+7.44%

3个月收益率

T

The Investment House LLC

+ 持有MOH

+7.16%

3个月收益率

M

Manning & Napier Advisors, LLC

+ 持有MOH

+6.49%

3个月收益率

T

The Baupost Group, L.L.C.

+ 持有MOH

+4.19%

3个月收益率

I

Ilex Capital Partners (Uk) LLP

+ 持有MOH

+0.76%

3个月收益率

MOH 常见问题 —— 由 Alphio AI 解答

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Molina Healthcare Inc is currently trading at $207.36, which is below several analyst price targets, including $220 from Wells Fargo and $218 from RBC Capital. The company has shown a solid year-to-date change of +16.19%, indicating positive momentum. However, the recent insider selling increased by 4513.69%, which raises concerns about future performance. Given these mixed signals, a hold is recommended as the stock approaches key resistance levels around $213.35, while the risks associated with insider selling and fluctuating earnings estimates suggest caution.

13 analysts cover MOH: 4 rate it Buy, 8 Hold and 1 Sell. The average price target is 180.85.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易